Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Shutting off the function of a single gene in the body could someday help victims of spinal cord injuries avoid paralysis, researchers announced Wednesday.
The discovery potentially opens the door to new treatments and improved long-term recovery from such injuries which often result in life-long damage and sky-high rehabilitation and hospitalization costs.
Researchers said they administered a drug to lab mice and rats that shut off a specific gene which kicks in after a spinal cord injury.
The gene, Abcc8, is part of the body's protective reaction in the event of spinal cord damage.
The gene activates the Sulfonylurea receptor-1 (Sur1) protein, which can paradoxically end up inflicting more damage to the spinal cord's own cells, according to lead researcher Marc Simard of the University of Maryland School of Medicine.
Sur1 uses sodium to protect cells from an excess of calcium that floods a severely injured area, but the defense mechanism sends the protein molecule into overdrive, allowing an unchecked influx of sodium into the cells, which can lead to cell death.
"By shutting down the Abcc8 gene that encodes the Sur1 protein the researchers were able to halt the self-destructive process and improve long-term recovery in spinal cord injured mice," according to a summary of the report published in Science Translational Medicine.
Simard's team studied spinal cord tissue from humans, mice and rats and found that the same process of cell death and destruction brought on by Sur1 was present in each of the species.
Shutting the gene off allowed researchers to preserve neurological function in the mice, with lesions between one-third and one-fourth the size of those in the control animals.
Researchers neutralized Abcc8 in mice using oligodeoxynucleotide, a short, single strand of DNA which clings to genes and temporarily blocks their activation.
About half of people with spinal cord injuries become paraplegic.
A sharp blow on the spine can fracture or dislocate the vertebrae, which in turn can crush and destroy the branches of neurons in the spinal cord which send signals to and from the brain.
Simard's research, which would still need years of clinical trials before a drug using the Abcc8 neutralizer can be sold publicly, lead to treatment which significantly reduces the destruction of nerve tissue in the aftermath of a spinal cord injury.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments